1. Home
  2. TRST vs PHAT Comparison

TRST vs PHAT Comparison

Compare TRST & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrustCo Bank Corp NY

TRST

TrustCo Bank Corp NY

HOLD

Current Price

$50.25

Market Cap

858.9M

Sector

Finance

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$11.31

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRST
PHAT
Founded
1902
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.9M
894.0M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
TRST
PHAT
Price
$50.25
$11.31
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$19.83
AVG Volume (30 Days)
67.4K
1.3M
Earning Date
04-21-2026
04-30-2026
Dividend Yield
3.25%
N/A
EPS Growth
26.46
42.72
EPS
0.91
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
N/A
$93.04
Revenue Next Year
N/A
$58.91
P/E Ratio
$55.44
N/A
Revenue Growth
N/A
216.93
52 Week Low
$30.17
$3.92
52 Week High
$50.52
$18.31

Technical Indicators

Market Signals
Indicator
TRST
PHAT
Relative Strength Index (RSI) 67.76 43.75
Support Level $41.96 $11.04
Resistance Level N/A $12.83
Average True Range (ATR) 0.89 0.73
MACD 0.11 -0.13
Stochastic Oscillator 82.95 8.04

Price Performance

Historical Comparison
TRST
PHAT

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: